Forus

Therapeutics

is a Canadian biopharmaceutical
company dedicated to advancing
differentiated, novel medicines
for hematologic malignancies
and other forms of cancer.

About Forus

Leadership

Values

Latest News

XPOVIO® Now Funded in Nova Scotia

XPOVIO® Now Funded in Nova Scotia

FORUS Therapeutics is pleased to announce that XPOVIO® (selinexor) is now publicly funded in Nova Scotia as of October 1st. Please see the following link for full funding criteria: Nova Scotia Pharmacare News Bulletins Pharmacy Edition (novascotia.ca) We are excited...

XPOVIO® Now Funded in British Columbia

XPOVIO® Now Funded in British Columbia

FORUS Therapeutics is pleased to announce that XPOVIO® (selinexor) is now publicly funded in British Columbia as of October 1, 2023. Further details on the criteria can be found here, under the MYBSD protocol: Lymphoma & Myeloma (bccancer.bc.ca) We are excited...

Contact Us

Mailing Address:

FORUS Therapeutics Inc.
200 North Service Road West, Suite 129
Oakville, Ontario, L6M 2Y1

Phone: 1-877-359-9595
Fax: 1-877-359-9590

Patient Support:

Phone: 1-833-4YOUPSP (1-833-496-8777)
Fax: 1-833-4YOUFAX (1-833-496-8329)

Product Support:

Phone: 1-866-542-7500
Fax: 1-866-542-1100

Do not use this form to report adverse events. Adverse events can be reported at 1-866-542-7500.